IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV12I3A67

The shrinking carotid stent

Stanislav Keranov*, MD; Ralf Zahn, MD; Uwe Zeymer, MD

A 77-year-old man with an asymptomatic 80% stenosis of the right internal carotid artery (ICA) underwent successful carotid artery stenting (CAS) with the Carotid WALLSTENT™, 7.0×30 mm (Boston Scientific, Marlborough, MA, USA) under distal embolic protection in February 2011 (Panel A, Panel B). Five months later he presented with a three-week history of intermittent dizziness and vision impairment. Cerebral magnetic resonance imaging (MRI) showed no signs of cerebral ischaemia. Angio MRI revealed a high grade restenosis of the right ICA. This finding was confirmed during angiography. It showed a 95% restenosis of the ICA in the same segment, just above the bifurcation, which was stenosed prior to stent implantation (Panel C). The stent was located proximally to the restenosis and appeared shorter in size now. Measurements showed a shrinkage of approximately 30% (Panel D, Panel E). A re-stenting using a Precise®, 7×30 mm (Cordis, Johnson & Johnson, Warren, NJ, USA) of the ICA under distal embolic protection was successfully performed (Panel F). A follow-up angio MRI two years later revealed no restenosis.

Delayed Carotid WALLSTENT shortening and restenosis can occur even after successful CAS. Therefore, regular short-term follow-up evaluation is important to detect unexpected complications such as stent shortening.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 12 Number 3
Jun 20, 2016
Volume 12 Number 3
View full issue


Key metrics

Suggested by Cory
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved